The Epidermal Growth Factor Receptor Inhibitor-Related Skin Toxicity Index (EGFRISTI): A New Tool for Grading and Managing Skin Adverse Reactions to Epidermal Growth Factor Receptor Inhibitors

Publisher： Karger

E-ISSN： 1423-0232|87|5|311-319

ISSN： 0030-2414

Source： Oncology, Vol.87, Iss.5, 2014-08, pp. : 311-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of epidermal growth factor receptor tyrosine kinase inhibitor‐related cutaneous and gastrointestinal toxicities

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 14, Iss. 1, 2018-02 ,pp. : 23-31

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor mRNA Is Not Increased in Psoriatic Skin

By  

THE JOURNAL OF DERMATOLOGY, Vol. 17, Iss. 2, 1990-02 ,pp. : 104-107

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact and Management of Skin Toxicity Associated with Anti-Epidermal Growth Factor Receptor Therapy: Survey Results

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 152-159

Karger

Access to resources Recommend Favorite

Treatment of Epidermal Growth Factor Receptor Antagonist-Induced Skin Rash: Results of a Survey among German Oncologists

By  

Oncology Research and Treatment, Vol. 33, Iss. 3, 2010-02 ,pp. : 94-98

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor (EGFR) Inhibitors in Gastrointestinal Cancer

By  

Oncology Research and Treatment, Vol. 29, Iss. 3, 2006-03 ,pp. : 99-105

Karger

Access to resources Recommend Favorite